4(1H)-quinolones with liver stage activity against Plasmodium berghei

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 417-424

  LaCrue, Alexis N ^a   Sáenz, Fabián E ^a,b   Cross, R Matthew ^a   Udenze, Kenneth O ^a   Monastyrskyi, Andrii ^a   Stein, Steven ^a   Mutka, Tina S ^a   Manetsch, Roman ^a   Kyle, Dennis E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE; CHLOROQUINE; ICI 56780; LUCIFERASE; P4Q 146; P4Q 158; PRIMAQUINE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

ANIMALS; ANTIMALARIALS; FEMALE; GENES, REPORTER; HEP G2 CELLS; HEPATOCYTES; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; LIVER; LUCIFERASES; MALARIA; MICE; MICE, INBRED BALB C; ORGANISMS, GENETICALLY MODIFIED; PLASMODIUM BERGHEI; QUINOLONES; SPOROZOITES;

EID: 84872007251     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00793-12     Document Type: Article

References (39)

1. Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379:413-431.
2. Shortt HE, Fairley NH, Covell G, Shute PG, Garnham PC. 1951. The pre-erythrocytic stage of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 44:405-419.
3. Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger A, Pollok JM, Menard R, Heussler VT. 2006. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313:1287-1290.
4. Alonso PL, Binka BQF, Brewer T, Chandra R, Culpepper J, Dinglasan R, Duncan K, Duparc S, Fukuda M, Laxminarayan R, MacArthur JR, Magill A, Marzetta C, Milman J, Mutabingwa T, Nosten F, Nwaka S, Nyunt M, Ohrt C, Plowe CV, Pottage J, Price R, Ringwald P, Serazin A, Shanks D, Sinden R, Tanner M, Vial H, Ward SA, Wellems TE, Wells T, White N, Wirth D, Yeung S, Yuthavong Y, Alonso PL, Djimde A, Magill A, Milman J, Nájera J, Plowe CV, Wells T, Yeung S, Kremsner P, Mueller I, Newman RD, Rabinovich R. 2011. A research agenda for malaria eradication: drugs. PLoS Med. 8:e1000402. doi:10.1371/journal.pmed. 1000402.
5. Dembele L, Gego A, Zeeman AM, Franetich JF, Silvie O, Rametti A, Le Grand R, Dereuddre-Bosquet N, Sauerwein R, van Gemert GJ, Vaillant JC, Thomas AW, Snounou G, Kocken CH, Mazier D. 2011. Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One 6:e18162. doi:10.1371/journal. pone.0018162.
6. Baird JK, Hoffman SL. 2004. Primaquine therapy for malaria. Clin. Infect. Dis. 39:1336-1345.
7. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. 2006. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am. J. Trop. Med. Hyg. 75:402-415.
8. Rodrigues T, Prudencio M, Moreira R, Mota MM, Lopes F. 2012. Targeting the liver stage of malaria parasites: a yet unmet goal. J. Med. Chem. 55:995-1012.
9. Vale N, Moreira R, Gomes P. 2009. Primaquine revisited six decades after its discovery. Eur. J. Med. Chem. 44:937-953.
10. Ziai M, Amirhakimi GH, Reinhold JG, Tabatabee M, Gettner ME, Bowman JE. 1967. Malaria prophylaxis and treatment in G-6-PD deficiency. An observation on the toxicity of primaquine and chloroquine. Clin. Pediatr. (Phila.) 6:242-243.
11. Salzer W, Andersag THH. 1948. A new type of compounds active against avian malaria. Chem. Ber. 81:12-19.
12. Puri SK, Dutta GP. 1990. Quinoline esters as potential antimalarial drugs: effect on relapses of Plasmodium cynomolgi infections in monkeys. Trans. R. Soc. Trop. Med. Hyg. 84:759-760.
13. Biagini GA, Fisher N, Shone AE, Mubaraki MA, Srivastava A, Hill A, Antoine T, Warman AJ, Davies J, Pidathala C, Amewu RK, Leung SC, Sharma R, Gibbons P, Hong DW, Pacorel B, Lawrenson AS, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Stocks PA, Nixon GL, Chadwick J, Hemingway J, Delves MJ, Sinden RE, Zeeman AM, Kocken CH, Berry NG, O'Neill PM, Ward SA. 2012. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. Proc. Natl. Acad. Sci. U. S. A. 109:8298-8303.
14. Cross RM, Monastyrskyi A, Mutka TS, Burrows JN, Kyle DE, Manetsch R. 2010. Endochin optimization: structure-activity and structureproperty relationship studies of 3-substituted 2-methyl-4(1H)- quinolones with antimalarial activity. J. Med. Chem. 53:7076-7094.
15. Cross RM, Namelikonda NK, Mutka TS, Luong L, Kyle DE, Manetsch R. 2011. Synthesis, antimalarial activity, and structure-activity relationship of 7-(2-phenoxyethoxy)-4(1H)-quinolones. J. Med. Chem. 54:8321-8327.
16. Pidathala C, Amewu R, Pacorel B, Nixon GL, Gibbons P, Hong WD, Leung SC, Berry NG, Sharma R, Stocks PA, Srivastava A, Shone AE, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Hill A, Fisher NE, Warman AJ, Biagini GA, Ward SA, O'Neill PM. 2012. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2). J. Med. Chem. 55:1831-1843.
17. Winter R, Kelly JX, Smilkstein MJ, Hinrichs D, Koop DR, Riscoe MK. 2011. Optimization of endochin-like quinolones for antimalarial activity. Exp. Parasitol. 127:545-551.
18. Winter RW, Kelly JX, Smilkstein MJ, Dodean R, Hinrichs D, Riscoe MK. 2008. Antimalarial quinolones: synthesis, potency, and mechanistic studies. Exp. Parasitol. 118:487-497.
19. Bruna-Romero O, Hafalla JC, Gonzalez-Aseguinolaza G, Sano G, Tsuji M, Zavala F. 2001. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int. J. Parasitol. 31:1499-1502.
20. Prudencio M, Mota MM, Mendes AM. 2011. A toolbox to study liver stage malaria. Trends Parasitol. 27:565-574.
21. Prudencio M, Rodrigues CD, Ataide R, Mota MM. 2008. Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry. Cell. Microbiol. 10:218-224.
22. Tarun AS, Baer K, Dumpit RF, Gray S, Lejarcegui N, Frevert U, Kappe SH. 2006. Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int. J. Parasitol. 36:1283-1293.
23. Coppi A, Cabinian M, Mirelman D, Sinnis P. 2006. Antimalarial activity of allicin, a biologically active compound from garlic cloves. Antimicrob. Agents Chemother. 50:1731-1737.
24. Panchal D, Bhanot P. 2010. Activity of a trisubstituted pyrrole in inhibiting sporozoite invasion and blocking malaria infection. Antimicrob. Agents Chemother. 54:4269-4274.
25. Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, Groessl T, Kato N, Lee MC, McNamara CW, Fidock DA, Nagle A, Nam TG, Richmond W, Roland J, Rottmann M, Zhou B, Froissard P, Glynne RJ, Mazier D, Sattabongkot J, Schultz PG, Tuntland T, Walker JR, Zhou Y, Chatterjee A, Diagana TT, Winzeler EA. 2011. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science 334:1372-1377.
26. Mwakingwe A, Ting LM, Hochman S, Chen J, Sinnis P, Kim K. 2009. Noninvasive real-time monitoring of liver-stage development of bioluminescent Plasmodium parasites. J. Infect. Dis. 200:1470-1478.
27. Ploemen IH, Prudencio M, Douradinha BG, Ramesar J, Fonager J, van Gemert GJ, Luty AJ, Hermsen CC, Sauerwein RW, Baptista FG, Mota MM, Waters AP, Que I, Lowik CW, Khan SM, Janse CJ, Franke-Fayard BM. 2009. Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging. PLoS One 4:e7881. doi:10.1371/journal.pone.0007881.
28. Ryley JF, Peters W. 1970. The antimalarial activity of some quinolone esters. Ann. Trop. Med. Parasitol. 64:209-222.
29. Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, van der Keur M, van der Linden R, Sinden RE, Waters AP, Janse CJ. 2004. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 137:23-33.
30. Janse CJ, Franke-Fayard B, Mair GR, Ramesar J, Thiel C, Engelmann S, Matuschewski K, van Gemert GJ, Sauerwein RW, Waters AP. 2006. High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol. Biochem. Parasitol. 145:60-70.
31. Lacrue AN, Scheel M, Kennedy K, Kumar N, Kyle DE. 2011. Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model Plasmodium vinckei. PLoS One 6:e26689. doi:10.1371/journal.pone.0026689.
32. Lacrue AN, James AA, Beerntsen BT. 2005. The novel Plasmodium gallinaceum sporozoite protein, Pg93, is preferentially expressed in the nucleus of oocyst sporozoites. Am. J. Trop. Med. Hyg. 73:634-643.
33. LaCrue AN, Sivaguru M, Walter MF, Fidock DA, James AA, Beerntsen BT. 2006. A ubiquitous Plasmodium protein displays a unique surface labeling pattern in sporozoites. Mol. Biochem. Parasitol. 148: 199-209.
34. Saenz FE, Balu B, Smith J, Mendonca SR, Adams JH. 2008. The transmembrane isoform of Plasmodium falciparum MAEBL is essential for the invasion of Anopheles salivary glands. PLoS One 3:e2287. doi: 10.1371/journal.pone.0002287.
35. Cross RM, Maignan JR, Mutka TS, Luong L, Sargent J, Kyle DE, Manetsch R. 2011. Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships. J. Med. Chem. 54:4399-4426.
36. Cohen RJ, Sachs JR, Wicker DJ, Conrad ME. 1968. Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam. N. Engl. J. Med. 279:1127-1131.
37. Coleman MD, Coleman NA. 1996. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf. 14:394-405.
38. Talisuna AO, Bloland P, D'Alessandro U. 2004. History, dynamics, and public health importance of malaria parasite resistance. Clin. Microbiol. Rev. 17:235-254.
39. Cross RM, Manetsch R. 2010. Divergent route to access structurally diverse 4-quinolones via mono or sequential cross-couplings. J. Org. Chem. 75:8654-8657.